FindTrial
Sign In

Establishment of a comprehensive evaluation system for early efficacy of patients with multidrug-resistant tuberculosis

Establishment of a comprehensive evaluation system for early efficacy of patients with multidrug-resistant tuberculosis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500100899
Enrollment
Unknown
Registered
2025-04-16
Start date
2025-04-30
Completion date
Unknown
Last updated
2025-04-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

multidrug-resistant tuberculosis

Interventions

Observation group:NA

Sponsors

Beijing Chest Hospital, Capital Medical Universit
Lead Sponsor

Eligibility

Sex/Gender
All
Age
16 Years to No maximum

Inclusion criteria

Inclusion criteria: 1 Patients with multidrug-resistant tuberculosis with laboratory diagnosis basis; 2 Multidrug-resistant treatment has not yet begun, or treatment has begun, and further treatment is still needed; 3 Age >= 16 years old.

Exclusion criteria

Exclusion criteria: 1 Patients with pulmonary resection or damage; 2 Patients with malignant tumor lesions; 3 Silicosis tuberculosis; 4 HIV carriers or HIV patients.

Design outcomes

Primary

MeasureTime frame
Bacteria load;—

Countries

China

Contacts

Public ContactYilin Wang

Beijing Chest Hospital, Capital Medical University

15040356701@163.com+86 186 1124 8789

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026